![](https://d3ilqtpdwi981i.cloudfront.net/m6i209gIsY7Uvv4ZWiC8f2ltRUY=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/f6/b2/c3/f6b2c399-6f97-453c-93ff-e6946c3c1a0c/thumbnail_7d4d36cc-4fb0-42cd-9d60-554d64f0d16b.jpg)
The emergence of antibiotic resistance over the past several decades has given urgency to new antibacterial strategies that apply less selective pressure. A new class of anti-virulence compounds were developed that are active against methicillin-resistant Staphylococcus aureus (MRSA), by inhibiting bacterial virulence without hindering their growth to reduce the selective pressure for resistance development. One of the compounds CCG-211790 has demonstrated potent anti-biofilm activity against MRSA. This new class of anti-virulence compounds inhibited the gene expression of virulence factors involved in biofilm formation and disrupted the biofilm structures. In this study, the physicochemical properties of CCG- 211790, including morphology, solubility in pure water or in water containing sodium dodecyl sulfate, solubility in organic solvents, and stability with respect to pH were investigated for the first time. Furthermore, a topical formulation was developed to enhance the therapeutic potential of the compound. The formulation demonstrated acceptable properties for drug release, viscosity, pH, cosmetic elegance and stability of over nine months.
- Bacterial biofilms,
- Solubility,
- Staphylococcus aureus,
- Antibiotic resistance,
- Vegetable oils,
- Organic solvents,
- Virulence factors,
- Bacterial pathogens
Available at: http://works.bepress.com/honglan-shi/97/
This work was supported by National Institutes of Health (NIH)